Foundayo
Beyond's analysis on Foundayo
- — UK launch of oral diabetes pill Foundayo signals new competition in weight‑loss drug market
- — Prescription drug sales projected to jump 62% to €1.7 trillion, driven by obesity and autoimmune therapies
Recent news mentioning Foundayo
- — Lilly Launches Foundayo in the UK as NICE Review Continues
- — Pilule antiobésité : le Foundayo, développé par le laboratoire américain Eli Lilly, autorisé au Royaume-Uni, une première en Europe